Cadrenal Therapeutics, Inc.
Close on Oct 19, 2026
- Market cap
- $3.09M
- P/E (TTM)
- –
- Dividend yield
- 1556.60%
Earnings
Next report expected Nov 9, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 13, 2026 | After market close | – | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | Before market open | – | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 31, 2026 | Before market open | – | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 10, 2025 | Before market open | – | – | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 11, 2025 | After market close | – | $-1.87 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | After market close | – | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 13, 2025 | After market close | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 7, 2024 | Before market open | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 8, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 11, 2024 | Before market open | – | – | – |
| Q3 FY2023 Ended Sep 30, 2023 | Nov 9, 2023 | Before market open | – | – | – |
Press releases
Announcements Cadrenal Therapeutics filed with the SEC
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON OCTOBER 7, 2026
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON AUGUST 31, 2026
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON AUGUST 13, 2026
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON JULY 21, 2026
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRICING PRESS RELEASE OF CADRENAL THERAPEUTICS, INC., DATED JUNE 30, 2026
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON JUNE 18, 2026
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON MAY 6, 2026
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON APRIL 30, 2026
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON MARCH 31, 2026
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON MARCH 12, 2026
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON FEBRUARY 24, 2026
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF CADRENAL THERAPEUTICS, INC. DATED DECEMBER 11, 2025
Material agreement · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
CORPORATE PRESENTATION DATED DECEMBER 2025
Material agreement · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
PRESS RELEASE OF CADRENAL THERAPEUTICS, INC. DATED DECEMBER 1, 2025
Executive or director change · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON NOVEMBER 10, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE OF CADRENAL THERAPEUTICS, INC. DATED SEPTEMBER 15, 2025
Material agreement · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
CORPORATE PRESENTATION DATED SEPTEMBER 2025
Material agreement · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON AUGUST 11, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON AUGUST 5, 2025
Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON MAY 8, 2025
Results of operations · EX-99.1 to Form 8-K
Therapeutics Reports Full Year 2024 Results, Business
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON MARCH 4, 2025
Material agreement · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY CADRENAL THERAPEUTICS, INC. ON FEBRUARY 6, 2025
Executive or director change · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON NOVEMBER 7, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY CADRENAL THERAPEUTICS, INC., DATED NOVEMBER 1, 2024 (PRICING OF THE OFFERING)
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON OCTOBER 24, 2024
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
INVESTOR PRESENTATION OF CADRENAL THERAPEUTICS, INC. DATED SEPTEMBER 2024
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON AUGUST 7, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE OF CADRENAL THERAPEUTICS, INC. DATED AUGUST 6, 2024
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATE APRIL 9, 2024
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON MARCH 11, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE OF CADRENAL THERAPEUTICS, INC., DATED FEBRUARY 8, 2024
Executive or director change · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON NOVEMBER 9, 2023
Results of operations · EX-99.1 to Form 8-K
INVESTOR PRESENTATION OF CADRENAL THERAPEUTICS, INC., DATED AUGUST 17, 2023
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON AUGUST 10, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE OF CADRENAL THERAPEUTICS, INC. DATED JULY 24, 2023
Executive or director change · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF CADRENAL THERAPEUTICS, INC. DATED JULY 12, 2023
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF CADRENAL THERAPEUTICS, INC. DATED JULY 14, 2023
Material agreement · Unregistered share sale · Other events · EX-99.2 to Form 8-K
PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON MAY 10, 2023
Results of operations · EX-99.1 to Form 8-K
INVESTOR PRESENTATION OF CADRENAL THERAPEUTICS, INC. DATED MARCH 2023
Regulation FD disclosure · EX-99.1 to Form 8-K